Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines

Qun Dai, Yi He Ling, Marie Lia, Yi Yu Zou, Glenn Kroog, Kenneth K. Iwata, Roman Perez-Soler

Research output: Contribution to journal › Article › peer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences